$NBIS

Volozh Arkadiy sold $11.0M of NBIS

Volozh Arkadiy (CEO) sold 46,627 shares of Nebius Group N.V. (NBIS) at $235.45 ($10.98M total) on 2026-07-01.

Original reporting
SEC EDGAR · Volozh Arkadiy
Published Jul 6, 2026, 3:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 3:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Neutral
medium confidence
Mentioned
$NBIS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISNeutralLow
01

Why it matters

The disclosed transaction is a quantified insider open-market sale by the CEO/10% owner, which can influence sentiment but does not introduce new company performance or guidance data.

02

Market read

Traders may reassess short-term sentiment around NBIS due to the size of the insider sale, but there is no fundamental catalyst in the text.

03

What to watch

The filing states 'Pre-arranged 10b5-1 plan: No,' which can increase interpretive sensitivity, but the article provides no stated reason for the sale.

Relevance 7/10Novelty 6/10Timing: new Form 4 filed 2026-07-06 (after-hours/market close timing not specified)

Background

The article is an SEC Form 4 insider transaction disclosure for Nebius Group N.V. (NBIS).

Company-level read

Ticker impact

$NBISNeutralMedium confidence
Context

SEC Form 4 shows CEO/10% owner Arkadiy Volozh sold 46,627 shares of NBIS for about $11.0M at $235.45/share on 2026-07-01.

Expected impact

Likely limited/short-lived sentiment impact; watch for follow-on insider activity or any concurrent company-specific news.

Evidence & confidence

The filing is primary-source and quantifies size/price, but it provides no new operational or guidance information and notes no 10b5-1 plan.

Market effects

Minimal; insider-sale filings typically do not reset sector expectations without accompanying company news.

Minimal; event is company-specific and not tied to a broader regional catalyst.

Low; no cross-border deal/regulatory action is described.

Counterpoint

A sale can be routine liquidity/portfolio rebalancing and may not signal negative outlook, especially if driven by personal tax or diversification needs.

Key entities

  • Nebius Group N.V.

    Subject of the Form 4 insider transaction; CEO/10% owner sold shares.

  • Volozh Arkadiy

    CEO, Officer/Director/10% Owner who reported the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.